Skip to main content
. Author manuscript; available in PMC: 2022 Nov 14.
Published in final edited form as: JAMA. 2021 Nov 9;326(18):1840–1850. doi: 10.1001/jama.2021.18323

Table 1.

Professional Society Guidelines for Management of Cardiogenic Shock (CS) Associated With Acute Myocardial Infarction (AMI)

Recommendation Recommendation
class
Level of
evidence
Year Society
Non-ST-elevation myocardial infarction (NSTEMI) with CS
Emergency coronary angiography I B 202027 ESC
Revascularization for cardiogenic shock I B 201428 ACCF/AHA
Emergency PCI of the culprit lesion is recommended for patients with CS due to NSTEMI, independent of the time delay from symptom onset, if the coronary anatomy is amenable to PCI I B 202027 ESC
Emergency CABG is recommended for patients with CS if the coronary anatomy is not amenable to PCI I B 202027 ESC
Routine immediate revascularization of nonculprit lesions in patients with NSTEMI with multivessel disease presenting with CS is not recommended III B 202027 ESC
ST-elevation myocardial infarction (STEMI) in CS
Immediate transfer to a PCI-capable hospital for coronary angiography is recommended for suitable patients with STEMI who develop CS irrespective of the time delay from MI onset I B 201326 ACCF/AHA
Cardiac catheterization and coronary angiography with intent to perform revascularization should be performed after STEMI in patients with CS I B 201326 ACCF/AHA
I B 201729 ESC
Primary PCI should be performed in patients with STEMI and CS irrespective of time delay from MI onset I B 201326 ACCF/AHA
PCI of an anatomically significant stenosis in the infarct artery should be performed in patients with suitable anatomy and CS I B 201326 ACCF/AHA
Patients who were treated with fibrinolytic therapy or who did not receive reperfusion therapy who develop CS associated with AMI should undergo coronary angiography I B 201326 ACCF/AHA
PCI of an infarct artery in patients who were treated with fibrinolytic therapy or who did not receive reperfusion therapy I B 201326 ACCF/AHA
Emergent CABG is indicated in patients with STEMI and coronary anatomy not amenable to PCI who have CS I B 201326 ACCF/AHA
Emergency revascularization with either PCI or CABG is recommended in suitable patients with CS after STEMI irrespective of the time delay from MI onset I B 201326 ACCF/AHA
In the absence of contraindications, fibrinolytic therapy should be administered to patients with STEMI and CS who are unsuitable candidates for either PCI or CABG I B 201326 ACCF/AHA
PCI of a noninfarct artery may be considered in select patients with STEMI and multivessel disease who are hemodynamically stable, either at the time of primary PCI or as a planned staged procedure IIb B 201326 ACCF/AHA
IIa C 201729 ESC
Pharmacotherapies
Inotropic/vasopressor agents may be considered for hemodynamic stabilization IIb C 201729 ESC
No specific recommendation 201326 ACCF/AHA
Temporary percutaneous mechanical circulatory support
IABP can be useful for patients with CS after STEMI who do not quickly stabilize with pharmacological therapy IIa B 201428 ACCF/AHA
Alternative LV assist devices for circulatory support may be considered in patients with refractory CS IIb C 201428 ACCF/AHA
In select patients with MI and CS, short-term mechanical circulatory support may be considered, depending on patient age, comorbidities, neurological function, and the prospects for long-term survival and predicted quality of life IIa C 201730 ESC
Routine use of IABP in patients with CS and no mechanical complications due to MI is not recommended III B 201729 ESC
Echocardiography
Immediate Doppler echocardiography is indicated to assess ventricular and valvular functions and loading conditions and to detect mechanical complications I C 201729 ESC

Abbreviations: ACCF, American College of Cardiology Foundation; AHA, American Heart Association; CABG, coronary artery bypass grafting; CS, cardiogenic shock; ESC, European Society of Cardiology; IABP, intra-aortic balloon pump; LV, left ventricle; PCI, percutaneous coronary intervention.